News & Events

Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014

Jan 21, 2016

Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014 for the potential development and commercialization of multiple antibody drug conjugates (ADCs). Siena, Italy, 21st January 2016.

  PRESS RELEASE PHILOGEN PFIZER ADC OPTION EXERCISE